• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    70 Stocks Moving In Monday's Mid-Day Session

    6/13/22 12:10:43 PM ET
    $ABVC
    $AEMD
    $AERC
    $ANY
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Dental Instruments
    Health Care
    Get the next $ABVC alert in real time by email

     

    Gainers

    • Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) shares jumped 110% to $13.93 after the company announced initial data from the pivotal FIREFLY-1 trial of tovorafenib in relapsed pediatric low-grade glioma showed an overall response rate of 64%.
    • Hillstream BioPharma, Inc. (NASDAQ:HILS) jumped 84% to $1.4713 after it authorized a share repurchase program to acquire up to $1 million in common stock.
    • G Medical Innovations Holdings Ltd (NASDAQ:GMVD) rose 74% to $0.6012 after dropping more than 28% on Friday.
    • bluebird bio, Inc. (NASDAQ:BLUE) gained 41.2% to $5.26. The FDA's Advisory Committee has unanimously backed Bluebird bio’s gene therapy for a rare blood disorder.
    • ABVC BioPharma, Inc. (NASDAQ:ABVC) jumped 35.8% to $1.2225 after dipping 49% on Friday.
    • Cerberus Cyber Sentinel Corporation (NASDAQ:CISO) gained 28% to $5.82.
    • Redbox Entertainment Inc. (NASDAQ:RDBX) shares rose 23.9% to $16.35 after jumping more than 39% on Friday.
    • AeroClean Technologies, Inc. (NASDAQ:AERC) gained 21.2% to $15.15.
    • Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) jumped 21.1% to $2.18. Ekso Bionics received FDA clearance to market its EksoNR robotic exoskeleton for use with multiple sclerosis patients.
    • OptiNose, Inc. (NASDAQ:OPTN) surged 18.9% to $2.20 after reporting top-line results of ReOpen2, its second Phase 3 clinical trial of XHANCE for the treatment of chronic sinusitis.
    • Belite Bio, Inc (NASDAQ:BLTE) gained 15.4% to $21.35.
    • Electro-Sensors, Inc. (NASDAQ:ELSE) gained 12.4% to $5.45. Electro-Sensors and Mobile X Global, Inc, a connectivity-as-a-service company, agreed to merge and re-name the combined company Mobile X Global, Inc.
    • Quanergy Systems, Inc. (NASDAQ:QNGY) rose 8.2% to $0.5840 after climbing 17% on Friday.

     

    Losers

    • Electric Last Mile Solutions, Inc. (NASDAQ:ELMS) shares tumbled 64.3% to $0.1823 after the company announced it plans to file for Chapter 7 bankruptcy.
    • NaaS Technology Inc. ADR (NASDAQ:NAAS) shares dipped 55.5% to $7.59.
    • Applied Blockchain, Inc. (NASDAQ:APLD) dropped 49.5% to $1.3850.
    • TDH Holdings, Inc. (NASDAQ:PETZ) shares dipped 42.8% to $0.1580. TDH Holdings reported a 1-for-20 reverse stock split.
    • BIT Mining Limited (NYSE:BTCM) fell 38% to $1.20.
    • Revlon, Inc. (NYSE:REV) fell 30.5% to $1.4250. Shares dropped more than 50% to on Friday following a report the company was expected to file for bankruptcy.
    • ContraFect Corporation (NASDAQ:CFRX) dropped 26% to $3.29. WBB Securities, last week, upgraded ContraFect from Buy to Strong Buy and announced a $7 price target.
    • Drive Shack Inc. (NYSE:DS) fell 25% to $1.3498.
    • Permianville Royalty Trust (NYSE:PVL) fell 25% to $4.26.
    • MicroStrategy Incorporated (NASDAQ:MSTR) shares fell 24.8% to $153.17 in sympathy with the price of Bitcoin and Ethereum.
    • Astra Space, Inc. (NASDAQ:ASTR) shares fell 24% to $1.5350 after rocket failed to deliver NASA weather satellites to orbit on Sunday.
    • Caribou Biosciences, Inc. (NASDAQ:CRBU) dropped 22.2% to $5.40. Caribou Biosciences recently reported additional data from the CB-010 allogeneic CAR-T cell therapy Phase 1 ANTLER trial at the European Hematology Association 2022 Hybrid Congress.
    • Volta Inc. (NYSE:VLTA) fell 22% to $1.7250 after Cantor Fitzgerald downgraded the stock from Overweight to Neutral and lowered its price target from $6 to $4.
    • Senti Biosciences, Inc. (NASDAQ:SNTI) declined 21.8% to $3.75.
    • SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) fell 20.7% to $2.26. SELLAS Life Sciences Group recently announced updated data from a Phase 1 clinical trial of galinpepimut-S (GPS), combined with Bristol-Myers Squibb’s nivolumab (Opdivo) in with malignant pleural mesothelioma (MPM).
    • Future FinTech Group Inc. (NASDAQ:FTFT) fell 20.7% to $0.3879.
    • Imperial Petroleum Inc. (NASDAQ:IMPP) dipped 20% to $0.7055. Imperial Petroleum entered into warrant exercise transaction for $21.8 million in gross proceeds.
    • Troika Media Group, Inc. (NASDAQ:TRKA) dropped 19.9% to $0.7534.
    • Ebang International Holdings Inc. (NASDAQ:EBON) declined 19.7% to $0.6017.
    • GeoVax Labs, Inc. (NASDAQ:GOVX) fell 19.7% to $1.1399.
    • SciSparc Ltd. (NASDAQ:SPRC) dropped 19.4% to $2.3214.
    • Valneva SE (NASDAQ:VALN) fell 19.2% to $16.16. Valneva said it is working on remediation plan for investigational COVID-19 vaccine.
    • Aethlon Medical, Inc. (NASDAQ:AEMD) fell 18.7% to $0.9101.
    • Marpai, Inc. (NASDAQ:MRAI) dipped 18.6% to $1.05.
    • Regis Corporation (NYSE:RGS) fell 18.4% to $0.5302. Regis shares jumped around 16% on Friday after the company announced a partnership with Zenoti.
    • Verb Technology Company, Inc. (NASDAQ:VERB) declined 18.2% to $0.36.
    • Renovacor, Inc. (NYSE:RCOR) dropped 18% to $1.4101.
    • Eros Media World Plc (NYSE:EMWP) declined 17.8% to $3.28.
    • SIGNA Sports United N.V. (NYSE:SSU) dropped 17.7% to $5.14.
    • Sphere 3D Corp. (NASDAQ:ANY) fell 17.7% to $0.7411.
    • Cumulus Media Inc. (NASDAQ:CMLS) dropped 17.7% to $9.46.
    • Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) fell 17.5% to $0.5424. Cyclerion Therapeutics shares dipped 20% on Friday after the company announced topline clinical data for CY6463 in MELAS patients at UMDF Mitochondrial Medicine 2022 Symposium.
    • Newegg Commerce, Inc. (NASDAQ:NEGG) dipped 17.3% to $4.0094.
    • Standard Lithium Ltd. (NYSE:SLI) declined 17.2% to $4.3699.
    • Renovare Environmental, Inc. (NASDAQ:RENO) dipped 17.2% to $0.2251.
    • LM Funding America, Inc. (NASDAQ:LMFA) dropped 16.8% to $0.9399.
    • Lulu's Fashion Lounge Holdings, Inc. (NASDAQ:LVLU) fell 16.8% to $11.77. B of A Securities recently downgraded Lulus Fashion Lounge from Buy to Neutral and raised the price target from $14 to $21.
    • DBV Technologies S.A. (NASDAQ:DBVT) fell 16.7% to $2.30 after declining 15% on Friday.
    • Mawson Infrastructure Group, Inc. (NASDAQ:MIGI) dropped 16.6% to $1.76.
    • Argo Blockchain plc (NASDAQ:ARBK) fell 16.3% to $4.7950 following a 5% decline on Friday.
    • Missfresh Limited (NASDAQ:MF) fell 16.1% to $0.2396.
    • CRISPR Therapeutics AG (NASDAQ:CRSP) declined 15.4% to $54.11. Stifel maintained CRISPR Therapeutics with a Hold and raised the price target from $52 to $57.
    • Neptune Wellness Solutions Inc. (NASDAQ:NEPT) dipped 15.3% to $3.22.
    • Coinbase Global, Inc. (NASDAQ:COIN) shares fell 14.9% to $49.96 after dropping 8% on Friday.
    • Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) dipped 14.7% to $1.28.
    • Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) fell 14.2% to $12.93.
    • Canaan Inc. (NASDAQ:CAN) fell 13.6% to $3.2224 in sympathy with the price of Bitcoin and Ethereum.
    • Pear Therapeutics, Inc. (NASDAQ:PEAR) dipped 13% to $2.01.
    • Mogo Inc. (NASDAQ:MOGO) fell 12.6% to $1.0050 after dropping 4% on Friday.
    • HIVE Blockchain Technologies Ltd. (NASDAQ:HIVE) fell 12.4% to $ 2.97 in sympathy with the price of Bitcoin and Ethereum.
    • Mainz Biomed B.V. (NASDAQ:MYNZ) fell 12.2% to $9.62.
    • Bitfarms Ltd. (NASDAQ:BITF) fell 12% to $1.40 in sympathy with the price of Bitcoin and Ethereum.
    • Hut 8 Mining Corp. (NYSE:HUT) fell 12% to $1.6550 after dropping 5% on Friday.
    • BIMI International Medical Inc. (NASDAQ:BIMI) fell 11.7% to $0.5962. BIMI International Medical shares jumped 30% on Friday after the company announced it entered a $5 million stock purchase agreement with chairman Fnu Oudom.
    • Riot Blockchain, Inc. (NASDAQ:RIOT) fell 10.3% to $ 4.6275 in sympathy with the price of Bitcoin and Ethereum.
    • Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) shares fell 9.3% to $3.28 after declining around 15% on Friday.
    • Kintara Therapeutics, Inc. (NASDAQ:KTRA) fell 8.9% to $0.2056.

     

    Get the next $ABVC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABVC
    $AEMD
    $AERC
    $ANY

    CompanyDatePrice TargetRatingAnalyst
    Hut 8 Corp.
    $HUT
    2/2/2026$80.00Buy
    H.C. Wainwright
    Coinbase Global Inc.
    $COIN
    1/28/2026$240.00Neutral
    Robert W. Baird
    Strategy Inc
    $MSTR
    1/27/2026$213.00Overweight
    Cantor Fitzgerald
    Coinbase Global Inc.
    $COIN
    1/27/2026$277.00Overweight
    Cantor Fitzgerald
    HIVE Digital Technologies Ltd.
    $HIVE
    1/27/2026$3.50Outperform → Mkt Perform
    Keefe Bruyette
    Bitfarms Ltd.
    $BITF
    1/27/2026$3.00Outperform → Mkt Perform
    Keefe Bruyette
    Arcturus Therapeutics Holdings Inc.
    $ARCT
    1/23/2026$20.00Buy
    Roth Capital
    Day One Biopharmaceuticals Inc.
    $DAWN
    1/13/2026$34.00Buy
    TD Cowen
    More analyst ratings

    $ABVC
    $AEMD
    $AERC
    $ANY
    SEC Filings

    View All

    SEC Form 6-K filed by Imperial Petroleum Inc.

    6-K - Imperial Petroleum Inc./Marshall Islands (0001876581) (Filer)

    2/9/26 9:23:26 AM ET
    $IMPP
    Marine Transportation
    Consumer Discretionary

    SEC Form 6-K filed by Bitfarms Ltd.

    6-K - Bitfarms Ltd (0001812477) (Filer)

    2/6/26 5:08:22 PM ET
    $BITF
    Finance: Consumer Services
    Finance

    SEC Form 144 filed by Coinbase Global Inc.

    144 - Coinbase Global, Inc. (0001679788) (Subject)

    2/6/26 3:35:00 PM ET
    $COIN
    Finance: Consumer Services
    Finance

    $ABVC
    $AEMD
    $AERC
    $ANY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    DBV Technologies to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit

    Châtillon, France, February 9, 2025 DBV Technologies to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit DBV Technologies (TRQX:DBVp) (the "Company"), a late-stage biopharmaceutical company, today announced Daniel Tassé, Chief Executive Officer, will participate in a fireside chat at the Guggenheim Securities Emerging Outlook: Biotech Summit which is being held February 11-12, 2026 in New York, NY. Mr. Tassé's presentation is scheduled for Thursday, February 12, at 2:30pm ET. A live webcast of the fireside chat can be accessed here and will also be available on the Events section of the Company's Investors website: https://dbv-technologies.com/investor-overview/ev

    2/9/26 4:30:00 PM ET
    $DBVT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Imperial Petroleum Announces $10 Million Share Repurchase Program

    ATHENS, Greece, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Imperial Petroleum Inc. (NASDAQ:IMPP) (the "Company") today announced that its Board of Directors has approved a share repurchase program and authorized the officers of the Company to repurchase, from time to time, up to $10,000,000 of the Company's common stock. Shares may be purchased in open market or privately negotiated transactions, at times and prices that are considered to be appropriate by the Company, and the program may be suspended or discontinued at any time. About Imperial Petroleum Inc. IMPERIAL PETROLEUM INC. is a ship-owning company providing petroleum products, crude oil and drybulk seaborne transportation services. The

    2/9/26 9:20:00 AM ET
    $IMPP
    Marine Transportation
    Consumer Discretionary

    Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 4.326 Million Tokens, and Total Crypto and Total Cash Holdings of $10.0 Billion

    Bitmine has 2,873,459 staked ETH, representing $6.2 billion at $2,125 per ETH; MAVAN staking solution on track to launch Q1 2026 Bitmine now owns 3.58% of the ETH token supply, over 72% of the way to the 'Alchemy of 5%' in just 6 months Bitmine recently closed on initial $200 million investment into Beast Industries Bitmine Crypto + Total Cash Holdings + "Moonshots" total $10.0 billion, including 4.326 million ETH tokens, total cash of $595 million, and other crypto holdings Bitmine leads crypto treasury peers by both the velocity of raising crypto NAV per share and by the high trading liquidity of BMNR stock Bitmine is the 107th most traded stock in the US, trading $1.3 billion per day (5-d

    2/9/26 8:30:00 AM ET
    $BMNR
    $COIN
    $MSTR
    Finance: Consumer Services
    Finance
    Computer Software: Prepackaged Software
    Technology

    $ABVC
    $AEMD
    $AERC
    $ANY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    H.C. Wainwright resumed coverage on Hut 8 Mining with a new price target

    H.C. Wainwright resumed coverage of Hut 8 Mining with a rating of Buy and set a new price target of $80.00

    2/2/26 6:51:37 AM ET
    $HUT
    Finance: Consumer Services
    Finance

    Robert W. Baird initiated coverage on Coinbase Global with a new price target

    Robert W. Baird initiated coverage of Coinbase Global with a rating of Neutral and set a new price target of $240.00

    1/28/26 7:16:37 AM ET
    $COIN
    Finance: Consumer Services
    Finance

    Cantor Fitzgerald resumed coverage on Strategy Inc with a new price target

    Cantor Fitzgerald resumed coverage of Strategy Inc with a rating of Overweight and set a new price target of $213.00

    1/27/26 8:49:50 AM ET
    $MSTR
    Computer Software: Prepackaged Software
    Technology

    $ABVC
    $AEMD
    $AERC
    $ANY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Endeavor Blockchain, Llc bought $192,502 worth of shares (42,100 units at $4.57), decreasing direct ownership by 100% to 4,397 units (SEC Form 4)

    4 - Mawson Infrastructure Group Inc. (0001218683) (Issuer)

    1/30/26 7:58:02 PM ET
    $MIGI
    Finance: Consumer Services
    Finance

    Chief Medical Officer Patel Naimish bought $49,704 worth of shares (1,508 units at $32.96) (SEC Form 4)

    4 - CRISPR Therapeutics AG (0001674416) (Issuer)

    1/27/26 5:35:15 PM ET
    $CRSP
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Large owner Endeavor Blockchain, Llc bought $290,400 worth of shares (60,000 units at $4.84), increasing direct ownership by 4% to 1,460,000 units (SEC Form 4)

    4 - Mawson Infrastructure Group Inc. (0001218683) (Issuer)

    1/26/26 7:22:56 PM ET
    $MIGI
    Finance: Consumer Services
    Finance

    $ABVC
    $AEMD
    $AERC
    $ANY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Smith Hunter C sold $702,744 worth of shares (6,628 units at $106.03), decreasing direct ownership by 5% to 125,537 units (SEC Form 4)

    4 - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Issuer)

    2/6/26 6:38:19 PM ET
    $RYTM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    New insider Asher Daniel claimed ownership of 321,763 shares (SEC Form 3)

    3 - EKSO BIONICS HOLDINGS, INC. (0001549084) (Issuer)

    2/5/26 6:20:48 PM ET
    $EKSO
    Industrial Machinery/Components
    Industrials

    Chief Financial Officer Crane Heidi was granted 34,837 shares (SEC Form 4)

    4 - Lulu's Fashion Lounge Holdings, Inc. (0001780201) (Issuer)

    2/5/26 4:05:16 PM ET
    $LVLU
    Catalog/Specialty Distribution
    Consumer Discretionary

    $ABVC
    $AEMD
    $AERC
    $ANY
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    April 30, 2024 - FDA Roundup: April 30, 2024

    For Immediate Release: April 30, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA published the FDA Voices: “A Milestone in Facilitating the Development of Safe and Effective Biosimilars,” by Sarah Yim, Director of the Office of New Drugs’ Office of Therapeutic Biologics and Biosimilars, Hilary Marston, M.D., M.P.H., and Patriz

    4/30/24 3:20:20 PM ET
    $DAWN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    April 26, 2024 - FDA Roundup: April 26, 2024

    For Immediate Release: April 26, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA published the FDA Voices: “A Milestone in Facilitating the Development of Safe and Effective Biosimilars,” by Sarah Yim, Director of the Office of New Drugs’ Office of Therapeutic Biologics and Biosimilars, Hilary Marston, M.D., M.P.H., and Patriz

    4/26/24 3:10:22 PM ET
    $DAWN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for OJEMDA issued to DAY ONE BIOPHARMACEUTICALS INC

    Submission status for DAY ONE BIOPHARMACEUTICALS INC's drug OJEMDA (ORIG-1) with active ingredient TOVORAFENIB has changed to 'Approval' on 04/23/2024. Application Category: NDA, Application Number: 218033, Application Classification: Type 1 - New Molecular Entity

    4/24/24 12:52:43 PM ET
    $DAWN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABVC
    $AEMD
    $AERC
    $ANY
    Leadership Updates

    Live Leadership Updates

    View All

    Lulus Appoints Heidi Crane as Permanent Chief Financial Officer

    CHICO, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Lulu's Fashion Lounge Holdings, Inc. ("Lulus" or the "Company") (NASDAQ:LVLU) today announced the appointment of Heidi Crane as its permanent Chief Financial Officer ("CFO"), effective February 4, 2026. Ms. Crane previously served as the Company's fractional CFO since October 13, 2025. "We're thrilled to have Heidi officially join our team as permanent CFO," said Crystal Landsem, CEO of Lulus. "After working closely with us in a fractional capacity, Heidi has demonstrated exceptional financial discipline, strategic insight, and a deep understanding of our business. Heidi's transition to Lulus' permanent CFO was a natural next step, and we'r

    2/5/26 4:03:00 PM ET
    $LVLU
    Catalog/Specialty Distribution
    Consumer Discretionary

    HIVE Digital Technologies Announces Filing and Mailing of Annual General and Special Meeting Materials

    Your vote is important - vote today.The Board of Directors unanimously recommends that Shareholders vote FOR the election of directors, appointment of auditors, amended incentive stock option plan, amended restricted share unit plan, and amendment to the shareholder quorum requirements at the annual general and special meeting.Shareholder questions or need voting assistance? Please contact Laurel Hill Advisory Group by email at [email protected], or by texting "INFO" to, or calling, 1-877-452-7184 (North American toll-free) or 1-416-304-0211 (outside North America).San Antonio, Texas--(Newsfile Corp. - January 28, 2026) - HIVE Digital Technologies Ltd. (TSXV:HIVE) (NASDAQ:HIVE) (FSE:

    1/28/26 6:31:00 PM ET
    $HIVE
    Finance: Consumer Services
    Finance

    MARPAI, INC. HIRES PHARMACY EXECUTIVE MIMI DAVIS AS PRESIDENT OF MARPAIRX TO DRIVE STRATEGIC GROWTH

    TAMPA, Fla., Jan. 27, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Pharmacy Benefit Management (PBM) and Third-Party Administration (TPA) services, announced the hiring of Mimi Davis as President of MarpaiRx. Davis, a distinguished leader in the pharmacy services sector, will oversee the strategic expansion and operational scaling of Marpai's pharmacy benefit offerings. Davis joins Marpai from Knipper Health, where she served as Executive Vice President of Operations. Her deep industry roots include a significant tenure at Eagle Pharmacy—a former HillCour portfolio company—which was acquired by Knipper in 2020. With

    1/27/26 8:23:00 AM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    $ABVC
    $AEMD
    $AERC
    $ANY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Newegg Commerce Inc.

    SC 13D/A - Newegg Commerce, Inc. (0001474627) (Subject)

    12/17/24 4:37:51 PM ET
    $NEGG
    Other Specialty Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by CRISPR Therapeutics AG

    SC 13G/A - CRISPR Therapeutics AG (0001674416) (Subject)

    12/10/24 1:34:45 PM ET
    $CRSP
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by Marpai Inc.

    SC 13D/A - Marpai, Inc. (0001844392) (Subject)

    12/9/24 5:14:07 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    $ABVC
    $AEMD
    $AERC
    $ANY
    Financials

    Live finance-specific insights

    View All

    Regis Corporation Reports Financial Results for the Second Fiscal Quarter 2026

    Transformation Efforts Gain Traction Across Supercuts and Corporate Networks Q2 Same-Store Sales for Supercuts Up 2.0%, Company-Owned Salons up 4.3%, Regis Consolidated Slightly Lower as Expected Due to Franchise Mix Loyalty Membership Enrollment Grows Steadily Regis Corporation (NASDAQGM:RGS), a leader in the haircare industry, today announced financial results for the second fiscal quarter ended December 31, 2025. Jim Lain, Regis Corporation's Interim President and Chief Executive Officer, commented, "Our second quarter results demonstrate improved execution and continued momentum, with same-store sales increasing 2.0% at Supercuts and 4.3% at company-owned salons. We delivered ye

    2/5/26 6:30:00 AM ET
    $RGS
    Other Consumer Services
    Consumer Discretionary

    Institutional-Grade Token Architecture Positions Companies at the Center of Digital Finance

    Scalable, compliant infrastructure supports demand for regulated digital assets for growing number of industries  Market News Updates News Commentary NEW YORK, Feb. 4, 2026 /PRNewswire/ -- Digital finance is moving fast, and institutional-grade token architecture is becoming a core piece of the financial system. Large investors and institutions want digital assets that are secure, compliant, and easy to integrate with traditional finance. Tokenized infrastructure built for institutions helps make that possible by supporting regulated transactions, asset-backed tokens, and scalable platforms designed for real-world use, not just experimentation as Active Companies take notice that may include

    2/4/26 8:45:00 AM ET
    $COIN
    $DJT
    $GNLN
    Finance: Consumer Services
    Finance
    Computer Software: Programming Data Processing
    Technology

    Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2026

    SAN DIEGO, Feb. 4, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ:AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that it will issue financial results for its fiscal third quarter ended December 31, 2025, at 4:15 p.m. ET on Thursday, February 12, 2026. Management will host a conference call on Thursday, February 12, 2026, at 4:30 p.m. ET to review financial results and recent corporate developments. Following management's formal remarks, there will be a question and answer session. Interested parties can register for the conference call by navigating to https://dpregister.com/sreg/10206585/1034

    2/4/26 8:01:00 AM ET
    $AEMD
    Medical/Dental Instruments
    Health Care